Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 15, Issue -, Pages 1677-1691
Publisher
Informa UK Limited
Online
2020-03-10
DOI
10.2147/ijn.s225807
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
- (2019) Amy L. Shergold et al. PHARMACOLOGICAL RESEARCH
- Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity
- (2018) Zili Gu et al. JOURNAL OF CONTROLLED RELEASE
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
- (2018) Shijie Xu et al. International Journal of Nanomedicine
- Catalase-Loaded TaOx Nanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy
- (2016) Guosheng Song et al. ADVANCED MATERIALS
- Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
- (2016) Andy J. Minn et al. CELL
- Targeting human melanoma neoantigens by T cell receptor gene therapy
- (2016) Matthias Leisegang et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Core-Shell MnSe@Bi2Se3Fabricated via a Cation Exchange Method as Novel Nanotheranostics for Multimodal Imaging and Synergistic Thermoradiotherapy
- (2015) Guosheng Song et al. ADVANCED MATERIALS
- Hypoxia-inducible factors in T lymphocyte differentiation and function. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Jin-Hui Tao et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2015) J. Naidoo et al. ANNALS OF ONCOLOGY
- Anti–PD-1 and Anti–PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
- (2015) Mahnaz Mellati et al. DIABETES CARE
- Toxicities of Immunotherapy for the Practitioner
- (2015) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
- (2015) Leila Arabi et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-Based Immunotherapy for Cancer
- (2014) Kun Shao et al. ACS Nano
- Drug delivery vehicles on a nano-engineering perspective
- (2014) Betiana Felice et al. Materials Science & Engineering C-Materials for Biological Applications
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature
- (2013) Shujing Shi et al. MEDICAL ONCOLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates
- (2012) Christopher Southan et al. DRUG DISCOVERY TODAY
- The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel
- (2011) Bing-Xiang Zhao et al. BIOMATERIALS
- Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?
- (2009) R. Fanciullino et al. CURRENT MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search